Loading…
Sectoral / Thematic · quant Mutual Fund · AMFI code 151853quant Healthcare Fund
Disclosed for 38 months, Aug 2023 to Sep 2026.
Portfolio value
₹372 Cr
up ₹20.6 Cr vs Apr 2026
- Stocks held
- 11
- down 4 vs Apr 2026
- Top 10 weight
- 80.4%
- of the portfolio in its ten largest
- Cash & debt
- 5.0%
quant Healthcare Fund is an active equity fund in the Sectoral / Thematic category from quant Mutual Fund. In May 2026 it disclosed 11 stocks worth ₹372 Cr, up ₹20.6 Cr from Apr 2026. Its largest positions were HFCL Limited (9.6%), Torrent Pharmaceuticals Ltd 30/06/2026 (9.4%), Divi's Laboratories Limited 30/06/2026 (9.3%); the ten largest together made up 80.4% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 52.0% of its equity. Cash and debt stood at 5.0%. Compared with Apr 2026 the fund entered 0 new stocks and exited 4.
Against 229 other Sectoral / Thematic funds
Concentration
98%
Top-10 weight is higher than 98% of peers
Breadth
0%
Holds more stocks than 0% of peers
Cash
70%
Holds more cash than 70% of peers
What these mean: concentration · cash
Holdings in May 2026
Download CSVEvery line the fund disclosed, with the change against Apr 2026. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| HFCL Limited | 9.55% | up 2.41 pts | ₹35.6 Cr | up ₹10.4 Cr | Added |
| Torrent Pharmaceuticals Ltd 30/06/2026 Derivative | 9.45% | up 9.45 pts | ₹35.2 Cr | up ₹35.2 Cr | New |
| Divi's Laboratories Limited 30/06/2026 Derivative | 9.33% | up 9.33 pts | ₹34.7 Cr | up ₹34.7 Cr | New |
| Zydus Wellness Limited | 8.74% | down 0.54 pts | ₹32.5 Cr | down ₹10 L | Held |
| Aster DM Healthcare Limited | 8.73% | down 0.16 pts | ₹32.5 Cr | up ₹1.2 Cr | Added |
| Anthem Biosciences Limited | 8.66% | down 0.51 pts | ₹32.2 Cr | down ₹1 L | Held |
| SMS Pharmaceuticals Limited | 7.66% | down 1.20 pts | ₹28.5 Cr | down ₹2.7 Cr | Trimmed |
| Glenmark Life Sciences Limited | 6.98% | down 0.29 pts | ₹26 Cr | up ₹43 L | Added |
| Pfizer Limited | 5.92% | down 0.50 pts | ₹22.1 Cr | down ₹54 L | Trimmed |
| HDFC Life Insurance Co Ltd 30/06/2026 Derivative | 5.39% | up 5.39 pts | ₹20.1 Cr | up ₹20.1 Cr | New |
| Aurobindo Pharma Limited | 4.95% | down 0.20 pts | ₹18.4 Cr | up ₹32 L | Added |
| HDFC Life Insurance Company Limited | 3.73% | down 0.07 pts | ₹13.9 Cr | up ₹53 L | Added |
| Strides Pharma Science Limited | 2.63% | up 2.33 pts | ₹9.8 Cr | up ₹8.7 Cr | Added |
| GlaxoSmithKline Pharmaceuticals Limited | 1.93% | down 0.23 pts | ₹7.2 Cr | down ₹41 L | Trimmed |
| Adani Green Energy Limited 30/06/2026 Derivative | 1.42% | up 1.42 pts | ₹5.3 Cr | up ₹5.3 Cr | New |
| 91 Days Treasury Bill 04-Jun-2026 Debt | 0.80% | down 0.04 pts | ₹3 Cr | up ₹1 L | Held |
| 91 Days Treasury Bill 16-Jul-2026 Debt | 0.80% | down 0.04 pts | ₹3 Cr | up ₹1 L | Held |
| 91 Days Treasury Bill 23-Jul-2026 Debt | 0.80% | down 0.04 pts | ₹3 Cr | up ₹1 L | Held |
| 91 Days Treasury Bill 06-Aug-2026 Debt | 0.80% | up 0.80 pts | ₹3 Cr | up ₹3 Cr | New |
| 91 Days Treasury Bill 13-Aug-2026 Debt | 0.80% | up 0.80 pts | ₹3 Cr | up ₹3 Cr | New |
| 91 Days Treasury Bill 20-Aug-2026 Debt | 0.80% | up 0.80 pts | ₹3 Cr | up ₹3 Cr | New |
| 91 Days Treasury Bill 28-Aug-2026 Debt | 0.79% | up 0.79 pts | ₹3 Cr | up ₹3 Cr | New |
| Cash, TREPS & receivables | −0.64% | down 5.74 pts | −₹2.4 Cr | down ₹20.3 Cr | Trimmed |
What changed, Apr 2026 to May 2026
New New positions (0)
None.
Exited Exited (4)
- Sequent Scientific Limitedwas 8.6% · ₹30.3 Cr
- ICICI Prudential Life Insurance Company Limitedwas 4.3% · ₹15.3 Cr
- MedPlus Health Services Limitedwas 3.7% · ₹13.1 Cr
- Gland Pharma Limitedwas 1.4% · ₹4.9 Cr
Added Biggest additions
- HFCL Limitedup ₹10.4 Cr (+2.41% pts)
- Strides Pharma Science Limited ₹8.7 Cr (+2.33% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Apr 2026, the weight rose most in Telecom - Services (+5.5 pts) and Pharmaceuticals (+3.4 pts), and fell most in Pharmaceuticals & Biotechnology (−4.7 pts) and Retailing (−4.3 pts).
- Telecom - Services8.3% → 13.7%+5.5 pts
- Pharmaceuticals0.3% → 3.8%+3.4 pts
- Healthcare Services10.3% → 12.6%+2.3 pts
- Food Products10.7% → 12.6%+1.9 pts
- Pharmaceuticals & Biotechnology56.7% → 52.0%−4.7 pts
- Retailing4.3% → 0.0%exited−4.3 pts
- Insurance9.4% → 5.4%−4.0 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | May 2025 | Nov 2025 | Feb 2026 | Apr 2026 | May 2026 |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 64.9% | 70.4% | 64.0% | 56.7% | 52.0% |
| Telecom - Services | 6.0% | — | — | 8.3% | 13.7% |
| Food Products | 7.2% | 9.2% | 8.5% | 10.7% | 12.6% |
| Healthcare Services | 14.4% | 9.9% | 10.1% | 10.3% | 12.6% |
| Insurance | 6.9% | — | 12.3% | 9.4% | 5.4% |
| Pharmaceuticals | — | — | — | 0.3% | 3.8% |
Allocation in May 2026change vs Apr 2026
- Pharmaceuticals & Biotechnology (6)52.0%▼ 4.7 pts
- Telecom - Services (1)13.7%▲ 5.5 pts
- Food Products (1)12.6%▲ 1.9 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, May 2026
5.0%
▼ 6.1 pts vs Apr 2026
- Cash alone
- −0.6%
- cash and net receivables
- A year earlier
- 0.2%
- May 2025 · now ▲ 4.7 pts
- Last 12 months
- 0.1% – 11.0%
- lowest to highest · record 11.0% in Apr 2026
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.